U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288372) titled 'The CGM-OGTT Glycemic Homeostasis Study' on Dec. 04.
Brief Summary: This is a prospective, exploratory, observational study aimed at investigating the mechanisms of glycemic homeostasis by comparing continuous glucose monitoring (CGM) data with results from the oral glucose tolerance test (OGTT).
The study plans to enroll approximately 225 participants aged 18-70 years who are at risk for or suspected of having glucose metabolism disorders, but without a prior diagnosis of diabetes. Participants will be equipped with a blinded CGM device for 10-14 days. During this period, they will perform two standardized mixed-meal tolerance tes...